Lacosamide
Also known as: Motpoly, Vimpat.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 10 MG/ML | Solution | $0.084 / mL | Generic |
| 50 MG | Tablet | $0.111 / unit | Generic |
| 100 MG | Tablet | $0.172 / unit | Generic |
| 100 MG | Capsule ER | $21.22 / unit | Brand |
| 100 MG/10 ML | (unspecified) | $0.084 / mL | Generic |
| 150 MG | Tablet | $0.208 / unit | Generic |
| 150 MG | Capsule ER | $21.29 / unit | Brand |
| 200 MG | Tablet | $0.277 / unit | Generic |
| 200 MG | Capsule ER | $21.30 / unit | Brand |
| 200 MG/20 ML | (unspecified) | $0.084 / mL | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates. Liquids, creams, and sprays are priced per mL or gram; a typical package may be a bottle or tube (size not set yet).
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $98,688,994 gross for Lacosamide across 706,502 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$110,945,835 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS